Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C1832588 (PSS)
 2,979 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We studied the biochemical properties and the reactivity of 13 monoclonal anti-thyroglobulin antibodies, obtained by fusing P3 X 63 (8653) myeloma cells with spleen cells from CBA and C57BL/6 mice previously immunized with syngeneic thyroglobulin. We demonstrated that among the 13 anti-thyroglobulin monoclonal antibodies that we studied, each of them was specific for only syngeneic thyroglobulin, as each of them was able to cross-react with heterologous or xenogeneic thyroglobulin. Two major kinds of monoclonal antibodies were obtained: the first ones are able to block in vitro primary syngeneic sensitization and, moreover, they mutually compete for thyroglobulin binding; the second ones are not involved in this in vitro PSS and do not compete for binding to thyroglobulin. These results suggest that a defined particular epitope, borne by thyroglobulin and expressed on the thyroid epithelial cells, is responsible for in vitro primary syngeneic sensitization.
 ...
PMID:Primary syngeneic sensitization on monolayers of thyroid epithelial cells. X. Inhibition of T-cell proliferative response by thyroglobulin-specific monoclonal antibodies. 243 39